Chronic Kidney Disease and Osteoporosis
CTF - Website
Osteoporosis and associated disorders
Materials
Additional Information
CHRONIC KIDNEY DISEASE & OSTEOPOROSIS
Date: April 10th, 2021 Speakers: Prof. Peter Ebeling & Dr. Essa Abuhelaiqa
Key learning objectives:
- Causes of increased fracture risk in CKD
- Assessing fracture risk in patients with CKD
- DXA, FRAX®, PTH, bone-specific ALP
- Effects of CKD on bone using novel imaging modalities
- Trabecular bone score (TBS)
- Advanced hip analysis on DXA
- High-resolution peripheral quantitative CT (HR-pQCT)
- Treating patients with CKD to reduce fractures
- Bisphosphonates, denosumab, teriparatide
- Safety of bisphosphonates and denosumab in CKD stage 3-5
- Understand the prevalence of osteoporosis among kidney transplant recipients in Qatar
- Understand potential osteoporosis risk factors in kidney transplant recipients in Qatar